Hi-Tech Pharmacal News

HI TECH PHARMACAL CO INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh

HI TECH PHARMACAL CO INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh

7 Small-Cap Stocks With Heavy Insider Ownership

HITK Makes Bullish Cross Above Critical Moving Average

In trading on Wednesday, shares of HI-Tech Pharmacal Co., Inc. crossed above their 200 day moving average of $34.35, changing hands as high as $34.57 per share.

HITK January 2014 Options Begin Trading

Investors in HI-Tech Pharmacal Co., Inc. saw new options begin trading today, for the January 2014 expiration.

Hi-Tech Pharmacal's Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)

Hi-Tech Pharmacal's Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)

Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Hi-Tech Pharmacal Co., Inc. today announced that it is scheduled to make an investor presentation at the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14, 2013, at 10:00 a.m.

Hi-Tech Pharma Announces ECR Pharma Re-Launched Zolpimist, DexPak, Divestiture of Hylase, Orbivan Brands

ECR Pharmaceuticals Announces Re-launch of Zolpimist® and DexPak®, Divestiture of Hylase® and Orbivan® Brands, and Dr. Cameron Durrant Named President and CEO

Hi-Tech Pharmacal Co., Inc. today announced that its ECR Pharmaceuticals division re-launched Zolpimist® Oral Spray and DexPak® Taperpaks (dexame

Hi-Tech Pharmacal to Present at the Needham 12th Annual Healthcare Conference

Hi-Tech Pharmacal Co., Inc. today announced that it is scheduled to make an investor presentation at the Needham 12th Annual Healthcare Conference Tuesday, April 29, 2013, at 10:40 a.m.

HI-Tech Pharmacal (HITK) Shares Cross Above 200 DMA

In trading on Tuesday, shares of HI-Tech Pharmacal Co., Inc. crossed above their 200 day moving average of $34.22, changing hands as high as $34.23 per share.

Why Hi-Tech Pharmacal May Be About to Take Off

Don't just ask, "How much inventory?" Ask, "What kind?"

Healthcare Sector: High Quality Stocks At A Great Value

Standpoint Research Upgrades Hi Tech Pharmacal (HITK) to Buy

HI TECH PHARMACAL CO INC Financials